Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Terumo "surprised" by Maquet's claims:

This article was originally published in Clinica

Executive Summary

Terumo Cardiovascular Systems (CVS), the Ann Arbor, Michigan-based subsidiary of Japanese group Terumo, has voiced its surprise at allegations that its VirturoSaph endoscopic vessel harvesting system infringed two US patents belonging to rival Maquet Cardiovascular. Terumo CVS vice-president of sales Mark DiClemente said that the patents related to VirturoSaph were several years old and that the system has been commercially available in the US for over three years. On the other hand, Maquet has only recently entered the market through an acquisition, he added. San Jose, California-based Maquet has filed concurrent complaints against Terumo in the US International Trade Commission (ITC) and the US district court of northern California. The ITC suit seeks to prevent Terumo's product from being imported into the US, while the Californian case seeks monetary damages and an injunction.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT046744

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel